Correlation Between Mangoceuticals, Common and Aclarion

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mangoceuticals, Common and Aclarion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mangoceuticals, Common and Aclarion into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mangoceuticals, Common Stock and Aclarion, you can compare the effects of market volatilities on Mangoceuticals, Common and Aclarion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mangoceuticals, Common with a short position of Aclarion. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mangoceuticals, Common and Aclarion.

Diversification Opportunities for Mangoceuticals, Common and Aclarion

0.9
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Mangoceuticals, and Aclarion is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding Mangoceuticals, Common Stock and Aclarion in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aclarion and Mangoceuticals, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mangoceuticals, Common Stock are associated (or correlated) with Aclarion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aclarion has no effect on the direction of Mangoceuticals, Common i.e., Mangoceuticals, Common and Aclarion go up and down completely randomly.

Pair Corralation between Mangoceuticals, Common and Aclarion

Given the investment horizon of 90 days Mangoceuticals, Common is expected to generate 2.93 times less return on investment than Aclarion. But when comparing it to its historical volatility, Mangoceuticals, Common Stock is 3.12 times less risky than Aclarion. It trades about 0.16 of its potential returns per unit of risk. Aclarion is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  3.90  in Aclarion on December 2, 2024 and sell it today you would earn a total of  3.35  from holding Aclarion or generate 85.9% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy85.25%
ValuesDaily Returns

Mangoceuticals, Common Stock  vs.  Aclarion

 Performance 
       Timeline  
Mangoceuticals, Common 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Mangoceuticals, Common Stock are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Mangoceuticals, Common showed solid returns over the last few months and may actually be approaching a breakup point.
Aclarion 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Aclarion are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Aclarion showed solid returns over the last few months and may actually be approaching a breakup point.

Mangoceuticals, Common and Aclarion Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mangoceuticals, Common and Aclarion

The main advantage of trading using opposite Mangoceuticals, Common and Aclarion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mangoceuticals, Common position performs unexpectedly, Aclarion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aclarion will offset losses from the drop in Aclarion's long position.
The idea behind Mangoceuticals, Common Stock and Aclarion pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios